Distance From Home to Hospital and Thrombolytic Utilization for Acute Ischemic Stroke

被引:15
作者
Acharya, Aninda B. [1 ]
Nyirenda, Joshua C. [2 ]
Higgs, Gary B. [2 ]
Bloomfield, Mark S. [3 ]
Cruz-Flores, Salvador [1 ]
Connor, Lisa T. [4 ,5 ]
Lee, Jin-Moo [5 ]
Leet, Terry L. [3 ]
机构
[1] St Louis Univ, Sch Med, Dept Neurol & Psychiat, St Louis, MO 63104 USA
[2] St Louis Univ, Geog Informat Syst Lab, St Louis, MO 63104 USA
[3] St Louis Univ, Sch Publ Hlth, Dept Community Hlth, St Louis, MO 63104 USA
[4] Washington Univ, Sch Med, Program Occupat Therapy, St Louis, MO USA
[5] Washington Univ, Sch Med, Dept Radiol & Neurol, St Louis, MO USA
关键词
Geographic information system; health care delivery; transportation of patients; Prehospital Emergency Care; TISSUE-PLASMINOGEN ACTIVATOR; ALTEPLASE; TIME; OUTCOMES; CENTERS; ONSET; DELAY;
D O I
10.1016/j.jstrokecerebrovasdis.2009.12.009
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Treatment of acute stroke with trombolytic therapy has been limited because of the narrow treatment window. Distance from home to hospital may affect arrival time and likelihood of receiving thrombolytic therapy for acute stroke. The present study included stroke subjects seen at Barnes Jewish Hospital in 2006-2007, residing in St Louis City/County, who were at home at the time of the stroke (n = 416). A network distance was calculated by mapping the best route from each subject's home to the hospital on a street network grid. Patients were grouped by distance into quintiles, and the group living the closest (group A, first quintile) was compared with the remainder of the cohort (group B). Outcomes of interest were rate of arrival within 3 hours of stroke onset (timely arrival) and rate of thrombolytic administration. The relative rate (RR) of each outcome was calculated for group A versus group B. A multivariate model of thrombolytic administration was created correcting for potential confounders. There was no difference in timely arrival between groups. The rate of thrombolytic administration was 13/100 for group B and 23/100 for group A, for an RR 0.55 (95% confidence interval [CI] 0.31-0.097) for group B versus group A. In the multivariate model, only National Institutes of Health Stroke Scale score was a significant confounder. The adjusted RR of thrombolytic treatment was 0.59 (95% CI, 0.34-0.99) for group B versus group A. Our data indicate that patients living in close proximity to the hospital are more likely to receive thrombolytic therapy for stroke compared with those living farther away. This finding cannot be explained by earlier arrival time.
引用
收藏
页码:295 / 301
页数:7
相关论文
共 21 条
[1]   Can Comprehensive Stroke Centers Erase the 'Weekend Effect'? [J].
Albright, Karen C. ;
Raman, Rema ;
Ernstrom, Karin ;
Hallevi, Hen ;
Martin-Schild, Sheryl ;
Meyer, Brett C. ;
Meyer, Dawn M. ;
Morales, Miriam M. ;
Grotta, James C. ;
Lyden, Patrick D. ;
Savitz, Sean I. .
CEREBROVASCULAR DISEASES, 2009, 27 (02) :107-113
[2]   Comparing alternative approaches to measuring the geographical accessibility of urban health services: Distance types and aggregation-error issues [J].
Apparicio, Philippe ;
Abdelmajid, Mohamed ;
Riva, Mylene ;
Shearmur, Richard .
INTERNATIONAL JOURNAL OF HEALTH GEOGRAPHICS, 2008, 7 (1)
[3]   Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility [J].
Barber, PA ;
Zhang, J ;
Demchuk, AM ;
Hill, MD ;
Buchan, AM .
NEUROLOGY, 2001, 56 (08) :1015-1020
[4]   Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset - The ATLANTIS study: A randomized controlled trial [J].
Clark, WM ;
Wissman, S ;
Albers, GW ;
Jhamandas, JH ;
Madden, KP ;
Hamilton, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (21) :2019-2026
[5]   Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial [J].
Davis, Stephen M. ;
Donnan, Geoffrey A. ;
Parsons, Mark W. ;
Levi, Christopher ;
Butcher, Kenneth S. ;
Peeters, Andre ;
Barber, P. Alan ;
Bladin, Christopher ;
De Silva, Deidre A. ;
Byrnes, Graham ;
Chalk, Jonathan B. ;
Fink, John N. ;
Kimber, Thomas E. ;
Schultz, David ;
Hand, Peter J. ;
Frayne, Judith ;
Hankey, Graeme ;
Muir, Keith ;
Gerraty, Richard ;
Tress, Brian M. ;
Desmond, Patricia M. .
LANCET NEUROLOGY, 2008, 7 (04) :299-309
[6]   Expansion of the Time Window for Treatment of Acute Ischemic Stroke With Intravenous Tissue Plasminogen Activator A Science Advisory From the American Heart Association/American Stroke Association [J].
del Zoppo, Gregory J. ;
Saver, Jeffrey L. ;
Jauch, Edward C. ;
Adams, Harold P., Jr. .
STROKE, 2009, 40 (08) :2945-2948
[7]   Delay between stroke onset and emergency department evaluation [J].
Goldstein, LB ;
Edwards, MG ;
Wood, DP .
NEUROEPIDEMIOLOGY, 2001, 20 (03) :196-200
[8]  
HACKE W, 1995, JAMA-J AM MED ASSOC, V274, P1017, DOI 10.1001/jama.274.13.1017
[9]   Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke [J].
Hacke, Werner ;
Kaste, Markku ;
Bluhmki, Erich ;
Brozman, Miroslav ;
Davalos, Antoni ;
Guidetti, Donata ;
Larrue, Vincent ;
Lees, Kennedy R. ;
Medeghri, Zakaria ;
Machnig, Thomas ;
Schneider, Dietmar ;
von Kummer, Ruediger ;
Wahlgren, Nils ;
Toni, Danilo .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (13) :1317-1329
[10]   Why are eligible thrombolysis candidates left untreated? [J].
Hills, Nancy K. ;
Claiborne Johnston, S. .
AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2006, 31 (06) :S210-S216